acetylcarnitine has been researched along with evans blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Abdul Muneer, PM; Alikunju, S; Haorah, J; Szlachetka, AM | 1 |
2 other study(ies) available for acetylcarnitine and evans blue
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitine.
Topics: Acetylcarnitine; Alcohols; Animals; Biological Transport; Blood-Aqueous Barrier; Cells, Cultured; Cerebral Cortex; Choline O-Acetyltransferase; Disease Models, Animal; Drug Interactions; Electric Impedance; Endothelial Cells; Evans Blue; Fetus; Glial Fibrillary Acidic Protein; Glucose; Glucose Transporter Type 1; Humans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Neural Inhibition; Neurodegenerative Diseases; Neurofilament Proteins; Neurons; Nootropic Agents; Phosphoproteins; Time Factors; Tyrosine 3-Monooxygenase; von Willebrand Factor; Zonula Occludens-1 Protein | 2011 |